News
This marks Aidoc's second FDA 510(k) so far this year.
A new study published in the Lancet found that patients using VR therapy had a significant reduction in agoraphobic avoidance and distress compared to participants receiving usual care.
The round brings the company's valuation to $1.1 billion.
The company said it will use the financing to expand in Europe and the U.S., and develop new digital therapeutics with its pharma partners.
Funding will be used to expand the firm’s digital health platform.
The new deal will provide Evry Health's Dallas-based members with Quit Genius' digital offerings.
BizBaz adds health scanning capabilities to its app that gamifies and rewards health and wellness activities.
The company uses AI-backed voice technology to help clinicians review mental health visits.
This new round brings the company's total funding to over $350 million.
The multiyear agreement will focus on speeding clinical trials and drug development in oncology and nonalcoholic steatohepatitis.